Scilex Holding Co (SCLXW) stock
SCLXWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLX
$0.04−0.00 (-1.53%)
Close on Oct 30, 2026Market cap $17.50MP/E –Yield –
Scilex statistics
69 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Oct 29, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 3.02
- 2.70
Share statisticsIndustry
- Shares Change (QoQ)
- -17.2%
- 0.54%
- Shares Held by Institutions
- 9.81%
- 56.1%
Short sellingIndustry
- Short Interest
- 171,151
- –
- Short Interest Change
- -3.15%
- 0.60%
- Days to Cover
- 5.76
- 4.58
Stock price statisticsIndustry
- 52-Week High
- $27.00
- –
- 52-Week Low
- $2.01
- –
- 20-Day Moving Average
- $2.82
- –
- 50-Day Moving Average
- $4.24
- –
- 200-Day Moving Average
- $6.92
- –
- Average True Range (14)
- $0.26
- –
- Price Change (1 Week)
- -16.6%
- 1.30%
- Price Change (1 Month)
- -53.7%
- -7.60%
- Price Change (3 Months)
- -69.1%
- -14.4%
- Price Change (6 Months)
- -80.4%
- -19.7%
- Price Change (YTD)
- -83.1%
- -19.6%
- Price Change (1 Year)
- -88.7%
- -21.9%
- Price Change (3 Years)
- -96.9%
- -22.6%
- Price Change (5 Years)
- -99.4%
- -75.5%
- Average Volume (10 Days)
- 38,349
- –
- Average Volume (20 Days)
- 49,467
- –
- Average Volume (90 Days)
- 81,218
- –
- Relative Volume
- 0.09
- 0.73
- Relative Strength Index (14)
- 15.8
- 44.2
- Volatility (1 Year)
- 100.9%
- 79.5%
- Beta (5 Years)
- 0.79
- 1.07
MarginsIndustry
- Pretax Margin
- -1469.7%
- -13.0%
- EBITDA Margin
- -1110.1%
- -30.5%
Returns on capitalIndustry
- Return on Assets (ROA)
- -275.4%
- -40.9%
Financial positionIndustry
- Current Ratio
- 0.07
- 3.30
- Quick Ratio
- 0.01
- 2.39
- Interest Coverage
- -22.20
- -6.26
GrowthIndustry
- Revenue Growth (YoY)
- -28.5%
- 5.65%
- Revenue Growth (3Y CAGR)
- -7.35%
- 2.17%
- Revenue Growth (5Y CAGR)
- 5.13%
- 6.47%
EfficiencyIndustry
- Asset Turnover
- 0.19
- 0.39
- Inventory Turnover
- 4.21
- 2.68
- Revenue Per Employee
- $929.65K
- $405.05K
- Profits Per Employee
- -$13.66M
- -$705.27K
- Employee Count
- 34
- 75
- WACC
- 11.3%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$464.55M
- -$14.23M
Balance sheetIndustry
- Net Cash (Debt)
- -$80.24M
- $15.31M
- Net Cash Per Share
- -$9.45
- $0.66
- Equity (Book Value)
- -$308.32M
- $48.79M
- Book Value Per Share
- -$36.30
- $1.36
- Tangible Book Value
- -$379.41M
- $23.91M
- Working Capital
- -$476.01M
- $74.41M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -2655.3%
- -20.7%
Taxes and interestIndustry
- Interest Expense
- $16.18M
- $3.07M
Scores and fair valueIndustry
- Altman Z-Score
- -12.74
- 0.25
- Piotroski F-Score
- 4
- 4
- Beneish M-Score
- -7.50
- -2.62
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.
| Period | SCLXW | S&P 500 | Difference | SCLXW per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -61.5% | -0.9% | −60.6 pts | ||
| 3 months | -72.7% | +2.1% | −74.8 pts | ||
| Year to date | -59.4% | +11.7% | −71.1 pts | ||
| 1 year | -83.2% | +12.4% | −95.6 pts | ||
| 3 years | -94.1% | +88.6% | −182.6 pts | -61.0% | +23.5% |
| 5 years | -93.1% | +75.9% | −169.1 pts | -41.5% | +12.0% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.
0M SCLXW shares were sold short on Oct 15, 2026, up 5.6% from the previous report. At recent volumes it would take 26.5 days to buy them back. Over the last 20 sessions, 75.6% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 15, 2026 | 178,361 | +5.6% | 6,728 | 26.5 |
| Sep 30, 2026 | 168,868 | -1.4% | 3,395 | 49.7 |
| Sep 15, 2026 | 171,290 | -3.4% | 4,831 | 35.5 |
| Aug 31, 2026 | 177,272 | -1.7% | 4,855 | 36.5 |
| Aug 14, 2026 | 180,421 | +0.5% | 901 | 200.3 |
| Jul 31, 2026 | 179,569 | +1.6% | 1,818 | 98.8 |
| Jul 15, 2026 | 176,809 | +5.2% | 6,524 | 27.1 |
| Jun 30, 2026 | 168,052 | +0.4% | 2,472 | 68.0 |
| Jun 15, 2026 | 167,405 | -0.1% | 2,208 | 75.8 |
| May 29, 2026 | 167,613 | -0.5% | 4,867 | 34.4 |
| May 15, 2026 | 168,490 | -0.2% | 4,648 | 36.3 |
| Apr 30, 2026 | 168,882 | +1.9% | 6,319 | 26.7 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.